Recurrent respiratory papillomatosis (RRP) is a potentially lethal disease caused by the human papillomavirus (HPV) and characterized by recurrent papillomas in the aerodigestive tract.

Recurrent respiratory papillomatosis (RRP) is a potentially lethal disease caused by the human papillomavirus (HPV) and characterized by recurrent papillomas in the aerodigestive tract.
Hearing loss in patients with vestibular schwannoma, both before and after treatment, is known to negatively impact quality of life.
Despite the increased morbidity and risks associated with revision surgery, select patients benefit from re-operation in the setting of recurrent well-differentiated thyroid cancer.
A look at how procedural therapies compare to other established pharmacologic and nonpharmacologic methods in treating patients with neurogenic cough.
Physician experts at the 2022 Triological Society Combined Sections Meeting discussed biologic therapy options for pediatrics chronic rhinosinusitis with polyps and recurrent respiratory papillomatosis.
Treatment for obstructive sleep apnea (OSA) continues to advance, from the increasingly sophisticated realm of wearables to new techniques for implantable devices.
Most patients who receive vocal fold lipoaugmentation for glottal insufficiency experience a long-term benefit, although improvements in voice and swallowing taper over time.
The literature supports the use of thyroglobylin washout as an adjunct to fine-needle aspiration cytology (FNAC) as it improves diagnostic accuracy.
Observation following a positive sentinel lymph node biopsy (SLNB) for head and neck cutaneous melanoma (HNCM) is likely a reasonable approach to offer patients, as survival is unchanged in prospective clinical trials.
There does not seem to be a one-size-fits-all treatment for adult patients with vocal fold sulcus or scars, suggesting the need for more subjective and objective decision-making tools.